LUC, What Is That?
暂无分享,去创建一个
[1] K. Pantel,et al. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] E. Wunders. Hematopoietic stem cells : the Mulhouse manual , 1994 .
[3] B. Tombal,et al. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of hematogenous prostate cells and standardization. , 1998, Clinical chemistry.
[4] C H Altshuler,et al. Data utilization, not data acquisition, is the main problem. , 1994, Clinical chemistry.
[5] M. Malatesta,et al. Immunoreactivity, ultrastructural localization, and transcript expression of prostate-specific antigen in human neuroblastoma cell lines. , 1999, Clinical chemistry.
[6] M. Hussain,et al. Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. , 1995, Cancer research.
[7] Erik Magid,et al. Improved Laboratory Test Selection and Enhanced Perception of Test Results as Tools for Cost-Effective Medicine , 1998, Clinical chemistry and laboratory medicine.
[8] J. Schwartz. Understanding laboratory test results. Conditions for appropriate use of laboratory tests. , 1987, The Medical clinics of North America.
[9] R. M. Sharrard,et al. Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction. , 1996, British Journal of Cancer.
[10] S. Chevillard,et al. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases. , 1997, Urology.